Loading clinical trials...
Loading clinical trials...
Investigation of Clinical Comparability of Semaglutide Drug Products Based on the Proposed and the Approved Drug Substance Manufacturing Processes in Participants With Type 2 Diabetes
The study compares two semaglutide medicines and looks at how well they control blood sugar levels, in participants with type 2 diabetes (T2D). Participants will either get the currently available semaglutide or the semaglutide which is produced through a new manufacturing process. Participants need to take one injection of semaglutide once a week, on the same day of every week. Participants will have a total of 11 clinic visits and the study will last for about 35 weeks (approximately 8 months).
Age
18 - 64 years
Sex
ALL
Healthy Volunteers
No
Prime Medical Group, LLC
Gilbert, Arizona, United States
FDRC
Costa Mesa, California, United States
Velocity Clinical Research San Diego
La Mesa, California, United States
Velocity Clin Res Los Angeles
Los Angeles, California, United States
LCGK Research
San Carlos, California, United States
San Diego Family Care_San Diego
San Diego, California, United States
Encompass Clinical Research_Spring Valley
Spring Valley, California, United States
Med Partners, Inc.
Toluca Lake, California, United States
University Clin Investigators
Tustin, California, United States
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Start Date
August 3, 2022
Primary Completion Date
August 9, 2023
Completion Date
September 18, 2023
Last Updated
December 12, 2025
388
ACTUAL participants
Semaglutide J
DRUG
Semaglutide B
DRUG
Lead Sponsor
Novo Nordisk A/S
NCT06959901
NCT06574035
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06861062